There are good reasons to evaluate the great business opportunity of Dermifant® !

May we introduce us as follows: DERMIFANT GmbH is a German company with a wide range of dermo cosmetic products for allergy prevention and therapy for babies and kids with a medical positioning.
Recently DERMIFANT took over the brand “Dermifant®” from ALLERGIKA Pharma GmbH, Germany, with the objective to build a nationally and internationally strong brand in the area of prevention and basic therapy of allergies and atopic dermatitis of babies and kids.
Please find in the following basic information about the Dermifant® product portfolio as well as its great and growing market potential. Allergies are in the rise especially also amongst kids and young people, not only in the western but in the meantime also in the third world countries!
There is no question that the market of allergies is of high interest but also especially the patient
group of babies and kids!
We are a highly motivated team and we are searching for potential partners which share our conviction that in this market of allergy prevention and treatment Dermifant® does have a great market potential and a successful future and for which Dermifant® may be a synergistic completion of an existing pediatric product portfolio or a new business opportunity with a very promising future.
In case of interest we are prepared to discuss with you Dermifant® and its business potential in more detail.
Please advise a convenient time.
Best regards,

Hartmut Bannert

Managing Director

1. Product portfolio
2. High market potential
3. USPs of Dermifant ®

1. Excellent active ingredients
2. Unique galenic formulations
3. Specially developed for babies and kids
4. The skin care from day one
5. Free of irritants and allergens:

  • Free of cortisone and urea
  • Free of fragrance, dyes, preservatives, parabens
  • Free of natural allergens and the 328 most common allergy triggers
4. Medical reasoning
  • The European Guideline for Allergy Prevention (S3). “Recommendation:
    In infants and children with visibly dry skin moisturizing creams should be used regularly”
    → e.g. Dermifant® Prevent

  • The European Guideline for the Treatment of Atopic Eczema/ Dermatitis of children:
    “Basic therapy with emollients is a part of every phase of the treatment”
    → e.g. Dermifant®-Basic Therapy

5. Trademark & registration
  • The Trademark Dermifant® is registered worldwide

  • For all Dermifant® products a fully updated registration documentation is available

  • Dermifant® products are already registered in all EU countries

  • Registration takes about 3-5 months, depending on the individual country authorization (outside EU)

6. Production

All Dermifant® products are produced exclusively in Germany under GMP

7. Target groups
  • The main target group are pediatricians
    Pediatricians see the babies and kids with high allergy risk and atopic dermatitis

  • Other target groups:
    Dermatologists, midwives, pharmacies and young families

8. Marketing & sales support

For all Dermifant® products there are fully developed marketing-, sales- and communication-tools available, as e.g.:

  • Salesfolder

  • Samples

  • Leaflets & brochures

  • Product overview

9. Our offer
  • Exclusive long-term distribution agreement

  • Interesting margins

  • Marketing & sales support

  • Sample support & promotional material

  • Training of salesforce

Internationally the specialist in the field of allergies in children

The name DERMIFANT® stands for tireless dedication in the service of babies and children with allergies and skin problems such as neurodermatitis. We are looking for partners worldwide who are also committed to the health of young patients.

Please contact us here:

    By submitting the contact form, you agree that your data may be used to process your request (for further information and revocation instructions, please refer to the privacy policy)